Full Press Release Details
Solid Biosciences Provides Fourth Quarter And Full Year 2023.
SLDB
Solid Biosciences Provides Fourth Quarter And Full Year 2023
Key Takeaway: Solid Biosciences Provides Fourth Quarter And Full Year 2023
Price reaction · baseline $11.4 (2024-03-12 close) · hit after-hours · clean, no other SLDB news in the window
day 0 close
+7.3%
day 1
+7.7%
day 3 · peak
+17.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma